Rhenopharm Ventures Private Limited
Founded in 2017 and headquartered in Maharashtra, India.
2017 | Nagpur, Maharashtra (India) | Active
Rhenopharm Ventures Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
About Rhenopharm Ventures
Rhenopharm Ventures Private Limited (RVPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 October 2017 (Seven years and four months 18 days old ). Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Krantichandra Bhave and Archana Dulichand serve as directors at the Company.
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999PN2017PTC172950
- Company No.
172950
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Oct 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Business Services
Who are the key members and board of directors at Rhenopharm Ventures?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krantichandra Bhave  | Director | 11-Oct-2017 | Current |
| Archana Dulichand | Director | 11-Oct-2017 | Current |
Financial Performance of Rhenopharm Ventures.
Enhance accessibility to Rhenopharm Ventures's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Rhenopharm Ventures?
Unlock access to Rhenopharm Ventures's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Godigiler India Web Solutions Private LimitedKrantichandra Bhave and Archana Dulichand are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rhenopharm Ventures?
Unlock and access historical data on people associated with Rhenopharm Ventures, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rhenopharm Ventures, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rhenopharm Ventures's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.